Reuters logo
BRIEF-Hikma gets FDA nod for Sodium Oxybate oral solution
January 18, 2017 / 9:31 AM / 10 months ago

BRIEF-Hikma gets FDA nod for Sodium Oxybate oral solution

Jan 18 (Reuters) - Hikma Pharmaceuticals Plc

* Hikma receives approval for Sodium Oxybate

* Receives approval for Sodium Oxybate oral solution

* Wholly owned US subsidiary, roxane has received an approval from US FDA for its Sodium Oxybate oral solution

* Roxane is currently involved in patent litigation concerning this product in us district court for district of New Jersey. Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below